P2-216: Screening for mild cognitive impairment and early AD with MAT (memory alteration test): Biological correlates

Screening for amnestic mild cognitive im

Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population

✍ L. Rami; J. L. Molinuevo; R. Sanchez-Valle; B. Bosch; A. Villar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract ## Objectives To design and validate a new screening test for amnestic Mild Cognitive Impairment (A‐MCI) and early stage Alzheimer's disease (AD). ## Methods We develop a verbal episodic and semantic memory test: the Memory Alteration Test (M@T). Discriminative validity was assessed